The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 2.9M data for 1.2M Compounds and 9.3K Targets. Of those, 1,352K data for 627K Compounds and 4.5K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

23 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Design, Palladium-Catalyzed Synthesis, and Biological Investigation of 2-Substituted 3-Aroylquinolin-4(1H)-ones as Inhibitors of the Hedgehog Signaling Pathway.EBI
Sapienza University of Rome
Design, Synthesis, and Pharmacological Evaluation of 2-(2,5-Dimethyl-5,6,7,8-tetrahydroquinolin-8-yl)-N-aryl Propanamides as Novel Smoothened (Smo) Antagonists.EBI
University of Chinese Academy of Sciences
Design, synthesis and biological characterization of a new class of osteogenic (1H)-quinolone derivatives.EBI
Universit£
Discovery of a 6-(pyridin-3-yl)benzo[d]thiazole template for optimization of hedgehog and PI3K/AKT/mTOR dual inhibitors.EBI
Soochow University
Identification of a novel Smoothened antagonist that potently suppresses Hedgehog signaling.EBI
Duke University Medical Center
Design, synthesis, and structure-activity-relationship of phenyl imidazoles as potent Smoothened antagonists.EBI
Genomics Institute of The Novartis Research Foundation
Macrocyclic Hedgehog Pathway Inhibitors: Optimization of Cellular Activity and Mode of Action Studies.EBI
TBA
Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened.EBI
TBA
Identification and structure-activity relationships of ortho-biphenyl carboxamides as potent Smoothened antagonists inhibiting the Hedgehog signaling pathway.EBI
Novartis Institutes For Biomedical Research
Discovery of amide replacements that improve activity and metabolic stability of a bis-amide smoothened antagonist hit.EBI
Amgen
Addressing PXR liabilities of phthalazine-based hedgehog/smoothened antagonists using novel pyridopyridazines.EBI
Amgen
Design of 1-piperazinyl-4-arylphthalazines as potent Smoothened antagonists.EBI
Amgen
1-amino-4-benzylphthalazines as orally bioavailable smoothened antagonists with antitumor activity.EBI
Novartis Institutes For Biomedical Research
Design, synthesis and biological evaluation of novel 4-aminopiperidine derivatives as SMO/ERK dual inhibitors.EBI
China Pharmaceutical University
Medulloblastoma drugs in development: Current leads, trials and drawbacks.EBI
University of Connecticut
Elucidation of Distinct Modular Assemblies of Smoothened Receptor by Bitopic Ligand Measurement.EBI
Shanghaitech University
Heteroarylamide smoothened inhibitors: Discovery of N-[2,4-dimethyl-5-(1-methylimidazol-4-yl)phenyl]-4-(2-pyridylmethoxy)benzamide (AZD8542) and N-[5-(1H-imidazol-2-yl)-2,4-dimethyl-phenyl]-4-(2- pyridylmethoxy)benzamide (AZD7254).EBI
Astrazeneca
Colocalization Strategy Unveils an Underside Binding Site in the Transmembrane Domain of Smoothened Receptor.EBI
Shanghaitech University
Structural optimization on a virtual screening hit of smoothened receptor.EBI
Soochow University
Structure-Activity Relationships for Itraconazole-Based Triazolone Analogues as Hedgehog Pathway Inhibitors.EBI
University of Connecticut
Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold.EBI
Sapienza University of Rome
Discovery and characterization of a potent Wnt and hedgehog signaling pathways dual inhibitor.EBI
Soochow University
Discovery of potent and novel smoothened antagonists via structure-based virtual screening and biological assays.EBI
Soochow University